Natsar Pharmaceuticals
Manufacturing · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4624 Tall Maple Ct, Ellicott City, Maryl...Phone Number
(410) 480-9226Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Natsar Pharmaceuticals
NATSAR Pharmaceuticals is an applied research and drug development company dedicated to creating innovative treatments for cancer and other diseases. The company focuses on the development of a small molecule inhibitor, RK33, targeting the RNA helicase DDX3, which is implicated in various cancer types. Their primary clients include healthcare providers and research institutions involved in oncology and drug development. NATSAR aims to advance clinical trials and provide effective therapies for patients suffering from cancers such as lung, breast, and sarcoma.Explore more
Natsar Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Natsar Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Natsar Pharmaceuticals launches new products
Check out if Natsar Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on Natsar Pharmaceuticals recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Natsar Pharmaceuticals has new funding data
Click to see if Natsar Pharmaceuticals had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Natsar Pharmaceuticals
Check if Natsar Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Natsar Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Natsar Pharmaceuticals
Find 2 more new buyers
Compare Similar Companies to Natsar Pharmaceuticals
Compare insights from companies similar to Natsar Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Natsar Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Natsar Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Natsar Pharmaceuticals.
Natsar Pharmaceuticals financials insights
Gather financial insights about Natsar Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Private Equity
$4.2M
Natsar Pharmaceuticals Tech Stack
A closer look at the technologies used by Natsar Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Natsar Pharmaceuticals
Sign Up For FreeTo access detailed company insights
NATSAR Pharmaceuticals is an applied research and drug development company dedicated to creating innovative treatments for cancer and other diseases. The company focuses on the development of a small molecule inhibitor, RK33, targeting the RNA helicase DDX3, which is implicated in various cancer types. Their primary clients include healthcare provi... Read More
